Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Extension Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Patients With Graves' Disease

NCT07286006 is registered in ClinicalTrials.gov with Immunovant Sciences GmbH as lead sponsor.

NCT NCT07286006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07286006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Extension Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Patients With Graves' Disease
Lead sponsor
Immunovant Sciences GmbH
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
January 26, 2026
Completion date
March 31, 2030
Enrollment
372 (estimated)
Sites
131

Conditions

As the registry lists them; a condition with its own page is linked.

graves' disease